June 29, 2026
Goodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches
B Findings validate the Alzheimer’s Drug Discovery Foundation’s long-standing leadership in advancing strategies that target the full pathobiology of the disease NEW YORK, May 5,…
